Despite test providers’ self-reported assertions of high accuracy, sensitivity and specificity, researchers confirm “…significant discordance…” between two types of popular clinical cancer tests prompting “…serious concerns about the risks of misguiding treatment decision to cancer patients” and a call for the establishment of international standards for tumor molecular profiling.